About RESILIENCI.AI — A PANDEMIC INSIGHTS COMPANY
Precision Movement Tools for
a Brighter Future
Precision movement solutions for a connected world.
We are determined to see life return to normal. That do that, people and businesses need to remain mobile, but in a mindful manner. Corporate efficiency failed to account for uncertainty. Today, success requires movement resiliency. Our collective ability to navigate during uncertain times. To stay connected. As a society and interconnected global economy.
Resilienci.ai is combining proprietary algorithms, artificial intelligence, and machine
learning to power a revolutionary human movement and business continuity platform. Our Roamwell suite of products help individuals and organizations remain mobile and operational by seeing and navigating hyper-local risks.
Why We Exist
Preserve mobility while reducing the impact of an uncertain world.
How We Do It
Precision resilience technologies to guide human and economic movement, choice, and continuity.
The World We Want
A connected, interactive, and flowing society.
The Resilienci.ai Team.
Leaders in the fields of artificial intelligence, public health, software development, finance, and governance.
We have enlisted some of the top minds in data science, public health and infectious disease management.
Resilienci.ai Founder and CEO
Mr. Klasson is an experienced entrepreneur and C-level executive responsible for leading multiple technology start-ups and companies through significant growth over his 40-year career. His early career was at Price Waterhouse, PepsiCo, ConAgra and FoxMeyer Corporation. For the past decade, he has successfully focused on developing AI and machine learning technology solutions. Klasson specializes in technology development, public/private research partnerships, business development, and corporate finance. He has completed private and public financings, and has significant international technology commercialization experience. His leadership roles include CFO, COO, President, and CEO.
Eric has served on multiple boards of non-profit and for-profit organizations. Eric received a Bachelor in Economics from the University of Michigan, an MBA from Texas A&M University, and completed USC’s Pharmaceutical Executive Development Program. Eric has been actively involved in addressing food insecurity issues for over three decades. His work includes director positions with the Monterey County Food Bank, Mobile Loaves & Fishes, and the Capital Area Food Bank and Foundation, where he served as Chairman.
Ms. Davies is Associate General Counsel at Edwards Lifesciences – a global leader in patient-focused medical innovations for structural heart disease. Ms. Daviess has more than 20 years of experience advising life science companies at all stages of development, and research institutions, across a broad range of business and legal issues. Ms. Davies has represented clients in State and Federal Courts and in front of administrative tribunals throughout the United States, and has advised clients and led interdisciplinary trial teams managing disputes on a global basis. She is also a licensed patent attorney, Ms. Davies was the Chief Intellectual Property Officer at the Cancer Prevention and Research Institute of Texas prior to joining Edwards.
Ms. Davies has substantial law firm management experience and has served at all levels of firm management, leading law firm business and practice development efforts. Prior to joining CPRIT, she was a partner with Gibson Dunn & Crutcher L.L.P., where she co-chaired the firm’s Life Sciences industry practice. Previously, Davies was a partner and member of the Executive Management Committee at Vinson & Elkins, L.L.P., where she led the firm’s Intellectual Property, Technology and Life Science practices. Ms. Davies also serves on several non-profit and academic advisory councils, including for the Center for Entrepreneurial and Economic Innovation at the University of Texas at Arlington.
Davies received her J.D. from the University of Minnesota, where she also earned a master’s degree in Public Health.
Cindy M. Matula
Mr. Campbell is founder and CEO of Campbell Global Service LLC. Campbell serves as Interim Chairman of the Board Executive Committee of the global East West Institute, the Lyndon Johnson School of Public Affairs, Austin Foreign Affairs Council, Access Health Care, Texas 2036, The Global Leaders Organization, and Tractus Corporation. Campbell previously spent 39 years with Deloitte & Touche, where he was a partner for 32 years, led the firm’s Public Sector practice for many years, co-founded the firm’s federal consulting practice, co-founded the firm’s Center for Health Innovation and Center for Cyber Solutions, and was a vice chairman of the firm. Campbell also served on the U.S. Federal Debt Commission of the Bipartisan Policy Center. Mr. Campbell holds a BA degree with honors from Austin College, where he is in the Athletic Hall of Honor, and an MPA degree from the University of Texas at Austin’s LBJ School of Public Affairs, where he was the 2013 Distinguished Public Service Award honoree.
Mr. Burgdorf is a partner at Hogan Lovells and has a multifaceted corporate practice in life sciences/biotech, healthcare, IT, software, and other technology markets as well as servicing clients in the higher education industry. As Vice-Chancellor and General Counsel of the University of Texas System for 9 years, Burgdorf regularly led its interactions with the federal government and oversaw areas that included legal, real estate, IT security, and technology transfer while serving as a member of UTS’s executive leadership team. He has been general counsel, outside counsel, and a c-level leader for both a life sciences and biotech venture capital fund and has served on numerous governing and advisory boards of technology and life sciences companies. Burgdorf holds a BA degree in finance and international business from the University of Texas at Austin, an MBA from Southern Methodist University, and a JD from the University of Texas School of Law.
Dr. Stephen Klasson, MD
Dr. Klasson practices at Harbin Clinic, where he has been a Board Certified Orthopedic Hand Surgeon for 29 years. Dr. Klasson is a practicing orthopedic hand surgeon in Rome, Georgia. During his career, he has held several physician and business leadership roles, including Director on the boards of Harbin Clinic, Heritage First Bancshare, Surgery Center of Rome, and Harbin Properties. Since 1996, Dr. Klasson has been a member of both the American Society for Surgery of the Hand and the American Academy of Orthopedic Surgeons. He holds a BA degree in History from Duke University and an MD from Vanderbilt University. Klasson is an investor in multiple privately-held manufacturing, professional services, and finance companies. He is also president of Health Creek Farm, LLC.
Mr. Bushong is Founder and Managing Director of Convergence Ventures, a venture capital fund dedicated to driving growth and development of leading-edge software-based solutions in healthcare, life sciences, and artificial intelligence. In 2005, he co-founded nanoTox, Inc. to focus on providing toxicology services for companies using nano-scale technology across a wide range of industries. nanoTox is now Material Intellect, focusing on machine learning and other advanced tools to enhance the research capabilities of corporations, academic institutions, and government laboratories. Harry has been an active investor in Advanced Throughput, Inc., a genomics company developing personalized medicine (acquired by privately-held Bastra, Ltd.) and Optokey, Inc., a bio-spectroscopic and environmental analysis company.